Black men’s prostate cancer may be more responsive to immunotherapy
Discovery paves way to precision medicine for prostate cancer in all races Northwestern University Increased level of plasma cells linked to improved cancer survival 1,300 prostate tumor samples studied Immunotherapy-based precision medicine clinical trials being developed CHICAGO— Black men die more often of prostate cancer yet, paradoxically, have greater survival benefits from immunotherapy treatment. A …
Black men’s prostate cancer may be more responsive to immunotherapy Read More »
